MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 182 filers reported holding MEDICINES CO in Q4 2013. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $76,800,000 | +1522.0% | 904,165 | +596.4% | 0.46% | +1423.3% |
Q2 2019 | $4,735,000 | -58.2% | 129,837 | -67.9% | 0.03% | -60.0% |
Q1 2019 | $11,320,000 | +42.9% | 405,000 | -2.1% | 0.08% | +31.6% |
Q4 2018 | $7,921,000 | -55.6% | 413,888 | -22.0% | 0.06% | -29.6% |
Q3 2018 | $17,825,000 | +470.2% | 530,500 | +522.8% | 0.08% | +478.6% |
Q2 2018 | $3,126,000 | -45.2% | 85,186 | -50.8% | 0.01% | -41.7% |
Q1 2018 | $5,701,000 | -62.5% | 173,065 | -56.7% | 0.02% | -61.9% |
Q2 2017 | $15,204,000 | +3435.8% | 400,000 | +4445.5% | 0.06% | +3050.0% |
Q1 2017 | $430,000 | -94.8% | 8,800 | -96.0% | 0.00% | -95.8% |
Q3 2016 | $8,277,000 | +55.1% | 219,305 | +38.2% | 0.05% | +37.1% |
Q2 2016 | $5,337,000 | +1952.7% | 158,700 | +1842.7% | 0.04% | +1650.0% |
Q1 2016 | $260,000 | -95.8% | 8,169 | -95.0% | 0.00% | -95.3% |
Q4 2015 | $6,126,000 | +114.1% | 164,054 | +64.1% | 0.04% | +138.9% |
Q2 2015 | $2,861,000 | -74.3% | 100,000 | -69.8% | 0.02% | -88.0% |
Q3 2013 | $11,115,000 | – | 331,600 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |